To be fair, 5% won't remove them. It only compels a meeting where a suitable motion can be put to shareholders.Will larger holders see reason? Who knows?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%